Increased growth inhibitory effects on human cancer cells and anti-inflammatory potency of shogaols from Zingiber officinale relative to gingerols

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 22, 2009, Pages 10645-10650

  Sang, Shengmin ^a,b   Hong, Jungil ^a,e   Wu, Hou ^c   Liu, Jing ^a   Yang, Chung S ^a   Pan, Min Hsiung ^d   Badmaev, Vladimir ^f   Ho, Chi Tang ^c  

^a RUTGERS UNIVERSITY   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^e Seoul Women University   (South Korea)

^f SABINSA CORPORATION   (United States)

Author keywords

6 gingerol; 6 shogaol; Cancer; Ginger; Inflammation; Zingiber officinale

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; CATECHOL DERIVATIVE; FATTY ALCOHOL; GINGEROL; NITRIC OXIDE; SHOGAOL;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CELL LINE; CELL STRAIN HCT116; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GINGER; HUMAN; LUNG TUMOR; MACROPHAGE; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; ARACHIDONIC ACID; CATECHOLS; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; FATTY ALCOHOLS; GINGER; HCT116 CELLS; HUMANS; LUNG NEOPLASMS; MACROPHAGES; MICE; NITRIC OXIDE;

ZINGIBER OFFICINALE;

EID: 72449141505     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf9027443     Document Type: Article

References (28)

1. Govindarajan, V. S. Ginger-Chemistry, technology, and quality evaluation: Part 1. Crit. Rev. Food Sci. Nutr. 1982, 17, 1-96.
2. Ravindran, P. N. B. N. K. Ginger: The Genus Zingiber; CRC Press: Boca Raton, FL, 2005; pp 1-15, 87-115.
3. Ali, B. H.; Blunden, G.; Tanira, M. O.; Nemmar, A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research, Food Chem. Toxicol. 2008, 46, 409-420. (Pubitemid 350297543)
4. Shukla, Y.; Singh, M. Cancer preventive properties of ginger: A brief review, Food Chem. Toxicol. 2007, 45, 683-690. (Pubitemid 46452881)
5. Surh, Y. J. Anti-tumor promoting potential of selected spice ingredients with, antioxidative and anti-inflammatory activities: A short review. Chem. Toxicol. 2002, 40, 1091-1097.
6. Park, K. K.; Chun, K. S.; Lee, J. M.; Lee, S. S.; Surh, Y. J. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin, tumor promotion in ICR mice. Cancer Lett. 1998, 129, 139-144.
7. KB in phorbol esterstimulated mouse skin. Oncogene 2005, 24, 2558-2567.
8. Kim, E. C; Min, J. K.; Kim, T. Y.; Lee, S. J.; Yang, H. O.; Han, S.; Kim, Y. M.; Kwon, Y. G. [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vitro and vivo. Biochem. Biophys. Res. Commun. 2005, 335, 300-308.
9. Jeong, C. H.; Bode, A. M.; Pugliese, A.; Cho, Y. Y.; Kim, H. G.; Shim, J. H.; Jeon, Y. J.; Li, H.; Jiang, H.; Dong, Z. [6]-Gingerol suppresses colon cancer growth, by targeting leukotriene A4 hydrolase. Cancer Res. 2009, 69, 5584-5591.
10. Pan, M, H.; Hsieh, M. C; Hsu, P. C; Ho, S. Y.; Lai, C. S.; Wu, H.; Sang, S.; Ho, C. T. 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Mol. Nutr. Food Res. 2008, 52, 1467-1477.
11. Rhode, J.; Fogoros, S.; Zick, S.; Wahl, H.; Griffith, K. A.; Huang, J.; Liu, J. R. Ginger inhibits cell growth and modulates angiogenic factors in ovarian, cancer cells. BMC Complementary Altern. Med. 2007, 7, 44.
12. Pan, M, H.; Hsieh, M. C; Kuo, J. M.; Lai, C. S.; Wu, H.; Sang, S.; Ho, C. T. 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression, Mol. Nutr. Food Res. 2008, 52, 527-537.
13. Kim, J. S.; Lee, S. I.; Park, H. W.; Yang, J. H.; Shin, T. Y.; Kim, Y. C; Baek, N. I.; Kim, S. H.; Choi, S. U.; Kwon, B. M.; Leem, K. H.; Jung, M. Y.; Kim, D. K. Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe. Arch. Pharm. Res. 2008, 31, 415-418.
14. Fang, X.; Qiu, F.; Yan, B.; Wang, H.; Mort, A. J.; Stark, R. E. NMR studies of molecular structure in fruit cuticle polyesters. Phytochemistry 2001, 57, 1035-1042.
15. Momann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
16. Ryu, J. H.; Ahn, H.; Jin Lee, H. Inhibition of nitric oxide production on LPS-activated macrophages by kazinol B from Broussonetia kazinoki. Fitoterapia 2003, 74, 350-354. (Pubitemid 36623297)
17. Charles, R.; Garg, S. N.; Kumar, S. New gingerdione from the rhizomes of Zingiber officinale. Fitoterapia 2000, 71, 716-718.
18. Shoji, N.; Iwasa, A.; Takemoto, T.; Ishida, Y.; Ohizumi, Y. Cardiotonic principles of ginger (Zingiber officinale Roscoe). J. Pharm. Sci. 1982, 71, 1174-1175. (Pubitemid 12032690)
19. Schwertner, H. A.; Rios, D. C. High-performance liquid chromatographic analysis of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol in ginger-containing dietary supplements, spices, teas, and beverages. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007, 856, 41-47.
20. Coulter, J. A.; McCarthy, H. O.; Xiang, J.; Roedl, W.; Wagner, E.; Robson, T.; Hirst, D. G. Nitric oxide-A novel therapeutic for cancer, Nitric Oxide 2008, 19, 192-198.
21. Hyde, C. A.; Missailidis, S. Inhibition of arachidonic acid metabolism and its implication, on cell proliferation and tumour-angiogenesis. Int. Immunopharmacol. 2009, 9, 701-715.
22. Benavente-Garcia, O.; Castillo, J. Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity, J. Agric. Food Chem. 2008, 56, 61.85-6205.
23. Sun, Z.; Sood, S.; Li, N.; Yang, P.; Newman, R. A.; Yang, C. S.; Chen, X. Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of a dual inhibitor of epidermal growth factor receptor (EGFR) and ErbB2 tyrosine kinases. Oral Oncol. 2008, 44, 652-657.
24. Thun, M. J.; Blackard, B. Pharmacologic effects of NSAIDs and implications for the risks and benefits of long-term prophylactic use of aspirin to prevent cancer, Recent Results Cancer Res. 2009, 181, 215-221.
25. Ha, S. K.; Lee, P.; Park, J. A.; Oh, H. R.; Lee, S. Y.; Park, J. H.; Lee, E. H.; Ryu, J. H.; Lee, K. R.; Kim, S. Y. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusioninduced focal ischemia mice model, Neurochem. Int. 2008, 52, 878-886.
26. Murakami, A. Chemoprevention with phytochemicals targeting inducible nitric oxide synthase, Forum Nutr. 2009, 61, 193-203.
27. Warren, C. A.; Paulhill, K. J.; Davidson, L. A.; Lupton, J. R.; Taddeo, S. S.; Hong, M. Y.; Carroll, R. J.; Chapkin, R. S.; Turner, N. D. Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. J. Nutr. 2009, 139, 101-105.
28. Yang, G. Y.; Taboada, S.; Liao, J. Induced nitric oxide synthase as a major player in the oncogenic transformation of inflamed tissue. Methods Mol. Biol. 2009, 512,119-156.